Alkermes News

Aktie
WKN:  A1JKVH ISIN:  IE00B56GVS15 US-Symbol:  ALKS
30,14 $
+0,75 $
+2,55%
26,272 € 30.03.26
Depot/Watchlist
Marktkapitalisierung *
3,94 Mrd. €
Streubesitz
100,00%
KGV
-
Index-Zuordnung
-

Alkermes News

30.04.25 - PR Newswire
New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)
New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD) PR Newswire
17.04.25 - PR Newswire
Alkermes to Report First Quarter Financial Results on May 1, 2025
Alkermes to Report First Quarter Financial Results on May 1, 2025 PR Newswire
17.04.25 - PR Newswire
Alkermes to Report First Quarter Financial Results on May 1, 2025
Alkermes to Report First Quarter Financial Results on May 1, 2025 PR Newswire
02.04.25 - PR Newswire
Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference
Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
02.04.25 - PR Newswire
Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference
Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
01.04.25 - PR Newswire
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia PR Newswire
01.04.25 - PR Newswire
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia PR Newswire

Newssuche

Videos

newspaper
30.03.26 -17,90%
Technical Trading 73% Trefferquote
GBP/USD Long Typ: Turbo Open End WKN: VG541T Hebel:30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »